CNBC August 15, 2024
Annika Kim Constantino

Key Points

– The Biden administration released prices for the first 10 prescription drugs that were subject to landmark negotiations with Medicare.

– The government estimates that the new prices could produce $6 billion in net savings for Medicare in 2026 alone, based on data from 2023.

– It is a milestone in a controversial process that aims to make costly medications more affordable for older Americans, a policy the pharmaceutical industry has opposed.

– It comes one day before the second anniversary of President Joe Biden’s signature Inflation Reduction Act.

The Biden administration on Thursday released prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and Medicare, a milestone in a controversial process...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech
Hospitals urge lawmakers to act as Medicare telehealth policies near expiration
Small practices, individual radiologists at a disadvantage in Medicare quality pay program
CMS Issues Final Rule on Returning Medicare and Medicaid Overpayments
Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023
Medicare Part D spending on weight loss drugs surges 364%: OIG

Share This Article